35. Zhang W., Wang N., Zhang T., Wang M., Ge W., Wang X. Roles of melatonin in goat hair follicle stem cell proliferation and pluripotency through regulating the Wnt signaling pathway. Front. Cell. Dev. Biol. 2021. vol. 9. P. 686805.
36. Maria S., Samsonraj R.M., Munmun F., Glas J., Silvestros M., Kotlarczyk M.P., Rylands R., Dudakovic A., van Wijnen A.J., Enderby L.T., et al. Biological effects of melatonin on osteoblast/osteoclast cocultures, bone, and quality of life: Implications of a role for MT2 melatonin receptors, MEK1/2, and MEK5 in melatonin-mediated osteoblastogenesis. J. Pineal Res. 2018. vol. 64. P.e12465.
37. Sotthibundhu A., Nopparat C., Natphopsuk S., Phuthong S., Noisa P., Govitrapong P. Combination of Melatonin and Small Molecules Improved Reprogramming Neural Cell Fates via Autophagy Activation. Neurochem Res. 2022. vol. 47. no. 9. P. 2580-2590.
38. Stazi M., Negro S., Megighian A., D'Este G., Solimena M., Jockers R., Lista F., Montecucco C., Rigoni M. Melatonin Promotes Regeneration of Injured Motor Axons via MT1 Receptors. J. Pineal Res. 2021. vol. 70. P. e12695.
39. Lee S., Byun J.K., Kim N.Y., Jin J., Woo H., Choi Y.K., Park K.G. Melatonin inhibits glycolysis in hepatocellular carcinoma cells by downregulating mitochondrial respiration and mTORC1 activity. BMB Rep. 2022. vol. 55. no. 9. P. 459-464.
40. Bu S., Wang Q., Sun J., Li X., Gu T., Lai D. Melatonin suppresses chronic restraint stress- mediated metastasis of epithelial ovarian cancer via NE/AKT/p-catenin/SLUG axis. Cell Death Dis. 2020. vol. 11. no. 8. P. 644.
41. Cucielo M.S., Cesario R.C., Silveira H.S., Gaiotte L.B., Dos Santos S.A.A., de Campos Zuccari D.A.P., Seiva F.R.F., Reiter R.J., de Almeida Chuffa L.G. Melatonin Reverses the Warburg-Type Metabolism and Reduces Mitochondrial Membrane Potential of Ovarian Cancer Cells Independent of MT1 Receptor Activation. Molecules. 2022. vol. 27. no. 14. P. 4350.
42. Talib W.H., Alsayed A.R., Abuawad A., Daoud S., Mahmod A.I. Melatonin in Cancer Treatment: Current Knowledge and Future Opportunities. Molecules. 2021. vol. 26. no. 9. P. 2506.
43. Kruk J., Aboul-Enein B.H., Duchnik E. Exercise-induced oxidative stress and melatonin supplementation: current evidence. J Physiol Sci. 2021. vol. 71. no. 1. P. 27.
44. Tan D.X., Manchester L.C., Esteban-Zubero E., Zhou Z., Reiter R.J. Melatonin as a Potent and Inducible Endogenous Antioxidant: Synthesis and Metabolism. Molecules. 2015. vol. 20. no. 10. P. 18886-18906.
45. Qin T., Feng D., Zhou B., Bai L., Yin Y. Melatonin Suppresses LPS-Induced Oxidative Stress in Dendritic Cells for Inflammatory Regulation via the Nrf2/HO-1 Axis. Antioxidants (Basel). 2022. vol. 11. no. 10. P. 2012.
46. Gao Y., Wu X., Zhao S., Zhang Y., Ma H., Yang Z., Yang W., Zhao C., Wang L., Zhang Q. Melatonin receptor depletion suppressed hCG-induced testosterone expression in mouse Leydig cells. Cell Mol Biol Lett. 2019. vol. 24. P. 21.
47. Chang T., Niu C., Sun C., Ma Y., Guo R., Ruan Z., Gao Y., Lu X., Li H., Lin Y., et al. Melatonin Exerts Immunoregulatory Effects by Balancing Peripheral Effector and Regulatory T Helper Cells in Myasthenia Gravis. Aging. 2020. vol. 12. P. 21147-21160.
48. Sooriyaarachchi P., Jayawardena R., Pavey T., King N.A. Shift work and the risk for metabolic syndrome among healthcare workers: A systematic review and meta-analysis. Obes Rev. 2022. vol. 23. no. 10. P. e13489.
49. Delpino F.M., Figueiredo L.M., Nunes B.P. Effects of Melatonin Supplementation on Diabetes: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Clin. Nutr. 2021. Vol. 40. P.4595-4605.
50. Ozkalayci F., Kocabas U., Altun B.U., Pandi-Perumal S., Altun A. Relationship Between Melatonin and Cardiovascular Disease. Cureus. 2021. vol. 13. no. 1. P. e12935.